Comparison Between Anterior Approach (Deltopectoral) and Lateral Approach (Deltoid Splitting) in Shoulder Reverse Arthroplasty for Proximal Humerus Fracture (DELTOSUPEX)

December 22, 2025 updated by: University Hospital, Clermont-Ferrand
The aim of the study consists in comparing two surgical approaches (deltopectoral versus lateral deltoid splitting) in the treatment of proximal humerus fractures treated with a reversed total shoulder arthroplasty The assessment will focus on clinical (clinical scores, efficacy, safety…) and radiological results, between these two types of surgical approaches by using a prospective, randomized analysis.

Study Overview

Detailed Description

The 2 main surgical approaches in total shoulder arthroplasty (TSA) are the anterior approach (deltopectoral) and the lateral one (deltoid splitting) (18).

Their advantages and drawbacks have not been clearly evaluated in proximal humerus fracture treated with an arthroplasty.

The goal of the study is to compare the results between patients (older than 65yo) presenting a proximal humerus fracture treated with a reversed shoulder arthroplasty performed through an anterior approach or a lateral one.

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Clermont-Ferrand, France, 63003
        • Chu Clermont-Ferrand

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient older than 65yo with a proximal humerus fracture (Neer 3-4 and 2 dislcated)
  • Patient registered to the national health system
  • Patient able to understand information about the protocol and answer to questionnaire

Exclusion Criteria:

  • Non-displaced fracture or no need of surgical treatment.
  • Existing bone disease
  • Infection
  • Neurological deficit (axillary nerve)
  • Multi-injured patients
  • Patient no able to fulfill the questionnaire
  • Patient refuses the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: deltopectoral approach
the patients are treated with deltopectoral approach surgery
Replacement of the proximal humeral head by a reversed prosthesis through an anterior approach
Other: lateral approach
the patients are treated with a lateral approach surgery
Replacement of the proximal humeral head by a reversed prosthesis through a lateral approach

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Constant Murley Score
Time Frame: 12 months
Constant Murley Score it a clinical method of functional assessment of the shoulder. The score varies between 0 and 100, more the value is better brought up is the score
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quick dash score
Time Frame: 3, 6 and 12 months
the Quick Dash score is a functional assessment of the shoulder. The score varies between 0 and 100, more the value is better brought up is the score
3, 6 and 12 months
SF12 score
Time Frame: 3, 6 and 12 months
The SF12 score is a quality of life assessment. The score varies between 0 and 100, more the value is better brought up is the score
3, 6 and 12 months
Alder score
Time Frame: 3, 6 and 12 months
Assessment of external rotation of the shoulder. The score varies between 0 and 100, more the value is better brought up is the score
3, 6 and 12 months
The Simple Shoulder Test (SST)
Time Frame: 3, 6 and 12 months
The Simple Shoulder Test is functional assessment of the shoulder. The score varies between 0 and 100, more the value is better brought up is the score
3, 6 and 12 months
WOOS (The Western Ontario Osteosarthritis )
Time Frame: 3, 6 and 12 months
The Western Ontario Osteosarthritis of the shoulder index is a quality of life measurement tool for osteoarthritis of the shoulder. The score varies between 0 and 100, more the value is better brought up is the score
3, 6 and 12 months
intensity of pain
Time Frame: pre op, 3, 6 and 12 months
THE VISUAL SIMILAR SCALE is auto-completed. For the intensity of pain, the scale varies between " no pain " (the score of 0) and " the pain so badly as he could be " or " the worst conceivable pain " (the score of 10)
pre op, 3, 6 and 12 months
Radiologic evaluation
Time Frame: pre op, 3, 6 and 12 months
Radiologic evaluation
pre op, 3, 6 and 12 months
Complications
Time Frame: pre op, 3, 6 and 12 months
list of the complications
pre op, 3, 6 and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Guillaume VILLATTE, University Hospital, Clermont-Ferrand

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 26, 2018

Primary Completion (Actual)

December 31, 2023

Study Completion (Actual)

June 30, 2024

Study Registration Dates

First Submitted

October 1, 2018

First Submitted That Met QC Criteria

October 1, 2018

First Posted (Actual)

October 3, 2018

Study Record Updates

Last Update Posted (Estimated)

December 30, 2025

Last Update Submitted That Met QC Criteria

December 22, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • CHU-410
  • 2018-A02113-52 (Other Identifier: 2018-A02113-52)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgical Approach

Clinical Trials on Reversed total shoulder arthroplasty

Subscribe